The potential bone health benefits of the olive polyphenol, oleuropein, are related to its ability to stimulate cells responsible for bone formation, says a new study that explains the mode of action of the compound.
Belgium-based BioActor has entered into a collaboration with one raw material supplier to jointly market a new olive polyphenol formulation currently under development to offer possible bone health benefits for food and drink.
The olive polyphenol, oleuropein, reduces bone loss in a rat model
of osteoporosis, say researchers at France's INRA, as science
continues to accumulate linking the olive extract with bone health.
Olive compounds appear to tackle the inflammation involved in
osteoporosis, says a new Belgian firm that wants to market this
novel intellectual property to supplement makers.